Variant report

Variant	nsv890355
Chromosome Location	chr8:11202154-11219334
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:612)
CpG islands
(count:1223)
Chromatin interactive
region (count:26)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:612 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr8:11213076-11213342	K562	blood:	n/a	n/a
2	ARID3A	chr8:11207682-11208854	K562	blood:	n/a	n/a
3	ARID3A	chr8:11204513-11204770	K562	blood:	n/a	n/a
4	ATF1	chr8:11207768-11208156	K562	blood:	n/a	n/a
5	ATF3	chr8:11204348-11204805	K562	blood:	n/a	n/a
6	ATF3	chr8:11207755-11208037	K562	blood:	n/a	n/a
7	ATF3	chr8:11204829-11205126	K562	blood:	n/a	chr8:11204842-11204862
8	ATF3	chr8:11207702-11208193	K562	blood:	n/a	n/a
9	ATF3	chr8:11204406-11204786	K562	blood:	n/a	n/a
10	ATF3	chr8:11219063-11219574	A549	lung:	n/a	n/a
11	ATF3	chr8:11206179-11206608	K562	blood:	n/a	chr8:11206194-11206208
12	BACH1	chr8:11204201-11206211	H1-hESC	embryonic stem cell:	n/a	n/a
13	BACH1	chr8:11204167-11204990	K562	blood:	n/a	n/a
14	BACH1	chr8:11207790-11208696	K562	blood:	n/a	chr8:11207913-11207927
15	BCL3	chr8:11217596-11217998	GM12878	blood:	n/a	n/a
16	BCL3	chr8:11217527-11217956	GM12878	blood:	n/a	chr8:11217549-11217558
17	BCL3	chr8:11204491-11204917	A549	lung:	n/a	n/a
18	BHLHE40	chr8:11204744-11205031	GM12878	blood:	n/a	n/a
19	BHLHE40	chr8:11207644-11208566	K562	blood:	n/a	n/a
20	BHLHE40	chr8:11213031-11213375	K562	blood:	n/a	n/a
21	BHLHE40	chr8:11204251-11205108	K562	blood:	n/a	n/a
22	BHLHE40	chr8:11205469-11205676	K562	blood:	n/a	n/a
23	BRCA1	chr8:11204539-11204641	H1-hESC	embryonic stem cell:	n/a	n/a
24	CBX3	chr8:11207602-11208626	K562	blood:	n/a	n/a
25	CBX3	chr8:11204397-11205076	K562	blood:	n/a	n/a
26	CBX3	chr8:11207603-11208161	K562	blood:	n/a	n/a
27	CCNT2	chr8:11207754-11208632	K562	blood:	n/a	n/a
28	CCNT2	chr8:11213058-11213305	K562	blood:	n/a	n/a
29	CCNT2	chr8:11204446-11205552	K562	blood:	n/a	n/a
30	CEBPB	chr8:11207735-11208581	K562	blood:	n/a	n/a
31	CEBPB	chr8:11218376-11218785	HepG2	liver:	n/a	n/a
32	CEBPB	chr8:11207679-11208588	K562	blood:	n/a	n/a
33	CEBPB	chr8:11219152-11219653	A549	lung:	n/a	n/a
34	CEBPB	chr8:11218115-11218312	K562	blood:	n/a	n/a
35	CEBPB	chr8:11204475-11204481	H1-hESC	embryonic stem cell:	n/a	n/a
36	CEBPB	chr8:11206288-11206541	K562	blood:	n/a	n/a
37	CEBPB	chr8:11218544-11218603	K562	blood:	n/a	n/a
38	CEBPB	chr8:11218497-11218734	HepG2	liver:	n/a	n/a
39	CEBPB	chr8:11206263-11206547	IMR90	lung:	n/a	n/a
40	CEBPB	chr8:11204360-11204656	K562	blood:	n/a	n/a
41	CEBPB	chr8:11219169-11219602	A549	lung:	n/a	n/a
42	CEBPB	chr8:11218039-11218768	HepG2	liver:	n/a	n/a
43	CEBPB	chr8:11218125-11218321	A549	lung:	n/a	n/a
44	CEBPB	chr8:11218070-11218740	HepG2	liver:	n/a	n/a
45	CEBPB	chr8:11219157-11219691	A549	lung:	n/a	n/a
46	CEBPD	chr8:11207619-11208681	K562	blood:	n/a	n/a
47	CEBPD	chr8:11208251-11208711	K562	blood:	n/a	n/a
48	CEBPD	chr8:11207631-11208228	K562	blood:	n/a	n/a
49	CHD1	chr8:11205294-11205467	H1-hESC	embryonic stem cell:	n/a	chr8:11205421-11205431
50	CHD2	chr8:11204448-11205241	K562	blood:	n/a	chr8:11205135-11205142

(count:1223 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:11204541-11204591	HL-60	blood:	n/a
2	chr8:11204681-11204731	HRCEpiC	kidney:	n/a
3	chr8:11213424-11213474	Caco-2	colon:	n/a
4	chr8:11204541-11204591	HL-60	blood:	n/a
5	chr8:11204681-11204731	HRCEpiC	kidney:	n/a
6	chr8:11213424-11213474	Caco-2	colon:	n/a
7	chr8:11204132-11204182	HCT-116	colon:	n/a
8	chr8:11204132-11204182	HEEpiC	esophagus:	n/a
9	chr8:11213424-11213474	BE2_C	brain:	n/a
10	chr8:11205972-11206022	PrEC	prostate:	n/a
11	chr8:11206023-11206073	Jurkat	blood:	n/a
12	chr8:11204132-11204182	SKMC	muscle:	n/a
13	chr8:11204017-11204067	K562	blood:	n/a
14	chr8:11203882-11203932	HEK293	kidney:	embryo
15	chr8:11212668-11212718	GM12892	blood:	n/a
16	chr8:11205155-11205205	HCPEpiC	choroid plexus:	n/a
17	chr8:11203954-11204004	AG04450	lung:	fetal
18	chr8:11205166-11205216	IMR90	lung:	fetal
19	chr8:11212812-11212862	PrEC	prostate:	n/a
20	chr8:11204132-11204182	Jurkat	blood:	n/a
21	chr8:11212812-11212862	U87	brain:	n/a
22	chr8:11204541-11204591	HNPCEpiC	eye:	n/a
23	chr8:11205166-11205216	AG09309	skin:	n/a
24	chr8:11203954-11204004	HAEpiC	amniotic membrane:	n/a
25	chr8:11204833-11204883	AG09309	skin:	n/a
26	chr8:11204681-11204731	MCF-7	breast:	n/a
27	chr8:11205754-11205804	HIPEpiC	eye:	n/a
28	chr8:11206009-11206059	BJ	skin:	n/a
29	chr8:11204132-11204182	GM06990	blood:	n/a
30	chr8:11203882-11203932	HL-60	blood:	n/a
31	chr8:11205247-11205297	GM06990	blood:	n/a
32	chr8:11205619-11205669	HRCEpiC	kidney:	n/a
33	chr8:11212812-11212862	K562	blood:	n/a
34	chr8:11206009-11206059	CMK	blood:	n/a
35	chr8:11207723-11207773	HIPEpiC	eye:	n/a
36	chr8:11212812-11212862	MCF-7	breast:	n/a
37	chr8:11205619-11205669	BE2_C	brain:	n/a
38	chr8:11204833-11204883	SK-N-MC	brain:	n/a
39	chr8:11205619-11205669	HIPEpiC	eye:	n/a
40	chr8:11205247-11205297	U87	brain:	n/a
41	chr8:11205247-11205297	BJ	skin:	n/a
42	chr8:11213517-11213567	AG09319	gingival:	n/a
43	chr8:11204132-11204182	HCPEpiC	choroid plexus:	n/a
44	chr8:11203882-11203932	AG09319	gingival:	n/a
45	chr8:11205247-11205297	HRE	kidney:	n/a
46	chr8:11213424-11213474	GM12878	blood:	n/a
47	chr8:11204017-11204067	HCT-116	colon:	n/a
48	chr8:11204833-11204883	Jurkat	blood:	n/a
49	chr8:11204681-11204731	HUVEC	blood vessel:	n/a
50	chr8:11204132-11204182	A549	lung:	n/a

(count:26 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr8:11210953..11213367-chr8:11221125..11223002,2	K562	blood:
2	chr8:11202880..11204738-chr8:11213241..11216075,2	K562	blood:
3	chr8:11205483..11207435-chr8:11216914..11218469,2	MCF-7	breast:
4	chr8:11203206..11204716-chr8:11251549..11254468,2	K562	blood:
5	chr8:11202670..11208385-chr8:11211112..11215163,10	K562	blood:
6	chr8:11200246..11202306-chr8:11227732..11229716,2	K562	blood:
7	chr8:11208459..11213186-chr8:11213672..11216072,5	K562	blood:
8	chr8:11208459..11213186-chr8:11213672..11216072,5	K562	blood:
9	chr8:11195675..11197986-chr8:11203854..11205997,2	MCF-7	breast:
10	chr8:11204525..11206554-chr8:11212652..11215291,3	MCF-7	breast:
11	chr8:11200722..11203684-chr8:11734586..11737466,2	K562	blood:
12	chr8:11214329..11216300-chr8:11221586..11223456,2	K562	blood:
13	chr8:11205483..11207435-chr8:11216914..11218469,2	MCF-7	breast:
14	chr8:11218476..11220050-chr8:11220905..11223351,2	K562	blood:
15	chr8:11204525..11206554-chr8:11212652..11215291,3	MCF-7	breast:
16	chr8:11141452..11143588-chr8:11203845..11206287,2	MCF-7	breast:
17	chr8:11213506..11215349-chr8:11216834..11218432,2	K562	blood:
18	chr8:11212238..11213947-chr8:11218852..11221758,2	MCF-7	breast:
19	chr8:11202670..11208385-chr8:11211112..11215163,10	K562	blood:
20	chr8:11202674..11205995-chr8:11206285..11210798,7	K562	blood:
21	chr8:11141950..11143471-chr8:11205387..11207796,2	K562	blood:
22	chr8:11202546..11204675-chr8:11207385..11211000,3	MCF-7	breast:
23	chr8:11193886..11197724-chr8:11199871..11205497,8	K562	blood:
24	chr8:11140914..11143471-chr8:11206296..11209213,2	K562	blood:
25	chr8:11205933..11210781-chr8:11211287..11215199,6	K562	blood:
26	chr8:11202546..11204675-chr8:11207385..11211000,3	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AF131216.5.1-1	chr8:11203257-11204149	ENSG00000255020.1
2	lnc-AF131216.5.1-1	chr8:11204806-11205011	ENSG00000255020.1

No data

Variant related genes	Relation type
TDH	TF binding region
ENSG00000255020	TF binding region
TDH	CpG island
ENSG00000255020	CpG island
ENSG00000255020	chromatin interactions
ENSG00000104643	chromatin interactions
ENSG00000154316	chromatin interactions

Extended variants
information (count: 935 )
Associated
traits (count: 138 )

Variant overlapped rSNPs/rCNVs (count:935 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11250129	chr8:11202154-11202155	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs551507963	chr8:11202156-11202157	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs539921080	chr8:11202158-11202159	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs373042424	chr8:11202192-11202193	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs527501923	chr8:11202193-11202194	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs77001309	chr8:11202235-11202236	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs558397601	chr8:11202264-11202265	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs183480370	chr8:11202318-11202319	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs537793657	chr8:11202345-11202346	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs550049863	chr8:11202375-11202376	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs571556567	chr8:11202377-11202378	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs538607826	chr8:11202399-11202400	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs187762037	chr8:11202405-11202406	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs147259123	chr8:11202443-11202444	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs536330328	chr8:11202446-11202447	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs554904424	chr8:11202453-11202454	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs576575290	chr8:11202471-11202472	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs112670605	chr8:11202525-11202526	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs377367820	chr8:11202547-11202548	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
20	rs534992085	chr8:11202555-11202556	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs565530717	chr8:11202571-11202572	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs140825280	chr8:11202629-11202630	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs76297127	chr8:11202659-11202660	Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
24	rs193090048	chr8:11202712-11202713	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs544990789	chr8:11202765-11202766	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs74921884	chr8:11202776-11202777	Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs114972960	chr8:11202841-11202842	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs144788698	chr8:11202868-11202869	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs560974902	chr8:11202894-11202895	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs531490057	chr8:11202904-11202905	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs549817469	chr8:11202949-11202950	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs11994376	chr8:11202960-11202961	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
33	rs201013396	chr8:11202996-11202997	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs538670741	chr8:11203072-11203073	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs11991153	chr8:11203107-11203108	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs73663103	chr8:11203123-11203124	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs555001152	chr8:11203235-11203236	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs576570351	chr8:11203255-11203256	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs537614593	chr8:11203256-11203257	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs559005948	chr8:11203338-11203339	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
41	rs13252025	chr8:11203367-11203368	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	mRNA abundance
42	rs200889471	chr8:11203369-11203370	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs202122221	chr8:11203371-11203372	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs61431050	chr8:11203424-11203425	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
45	rs189911226	chr8:11203426-11203427	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
46	rs13278577	chr8:11203436-11203437	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
47	rs199783108	chr8:11203439-11203440	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
48	rs55876722	chr8:11203440-11203441	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
49	rs375908220	chr8:11203441-11203442	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
50	rs57213851	chr8:11203442-11203443	Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:138)

Disease	PMID	Source
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
Prostate cancer	16573809	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Autism	22495311	CNVD
Myelofibrosis	22110671	CNVD
Intellectual disability	22045946	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Breast cancer	16608533	CNVD
Seminomas	18059402	CNVD
Lung cancer	18438408	CNVD
Lung squamous cell carcinoma	22363434	CNVD
Medulloblastoma	16783165	CNVD
Gastric cancer	18160780	CNVD
Breast cancer	21990379	CNVD
Psoriasis	20403174	CNVD
Psoriasis	20663923	CNVD
Crohn''s disease	16909382	CNVD
Cancer	21129771	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Crohn''s disease	20877625	CNVD
Inflammatory disorder	20877625	CNVD
Cardiac defect	21933911	CNVD
Psoriasis	18059266	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Psoriasis	20877625	CNVD
Mental retardation	17847001	CNVD
Prostate cancer	17217626	CNVD
Schizophrenia	21399695	CNVD
Colorectal cancer	21128281	CNVD
Colorectal cancer	19455253	CNVD
Psoriasis	18848619	CNVD
Squamous cell cancer	19047905	CNVD
Colorectal cancer	17229543	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Myxofibrosarcoma	16751306	CNVD
Immune disease	21572526	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Kallmann Syndrome 2	22470819	CNVD
Developmental disorder	20461109	CNVD
abnormal development	18461090	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Glioblastoma multiforme	21138945	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Gastric cancer	21811585	CNVD
Colorectal cancer	16774939	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:526 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:11194800-11204200	Weak transcription	Brain Anterior Caudate	brain
2	chr8:11195400-11202800	Weak transcription	K562	blood
3	chr8:11202000-11202200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
4	chr8:11202000-11202800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
5	chr8:11202200-11202800	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
6	chr8:11202200-11202800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
7	chr8:11202800-11203000	Enhancers	H1 Cell Line	embryonic stem cell
8	chr8:11202800-11203000	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
9	chr8:11202800-11203000	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
10	chr8:11202800-11203000	Enhancers	K562	blood
11	chr8:11202800-11204400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
12	chr8:11202800-11204400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
13	chr8:11202800-11206200	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
14	chr8:11202800-11207200	Active TSS	Pancreas	Pancrea
15	chr8:11203000-11203400	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
16	chr8:11203000-11203600	Weak transcription	K562	blood
17	chr8:11203000-11204200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
18	chr8:11203000-11204400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
19	chr8:11203400-11203800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
20	chr8:11203600-11203800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
21	chr8:11203600-11203800	Genic enhancers	K562	blood
22	chr8:11203600-11204000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
23	chr8:11203600-11204000	Enhancers	Gastric	stomach
24	chr8:11203600-11204200	Enhancers	H9 Cell Line	embryonic stem cell
25	chr8:11203600-11204200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
26	chr8:11203600-11204400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
27	chr8:11203800-11204000	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
28	chr8:11203800-11204000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
29	chr8:11203800-11204000	Transcr. at gene 5' and 3'	K562	blood
30	chr8:11203800-11204200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
31	chr8:11203800-11204200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
32	chr8:11203800-11204400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
33	chr8:11203800-11204400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
34	chr8:11203800-11204400	Enhancers	Fetal Heart	heart
35	chr8:11203800-11204600	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
36	chr8:11203800-11204600	Bivalent Enhancer	Fetal Lung	lung
37	chr8:11203800-11204600	Bivalent/Poised TSS	Stomach Smooth Muscle	stomach
38	chr8:11203800-11206200	Bivalent Enhancer	Placenta	Placenta
39	chr8:11204000-11204200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
40	chr8:11204000-11204200	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
41	chr8:11204000-11204200	Flanking Bivalent TSS/Enh	Brain Cingulate Gyrus	brain
42	chr8:11204000-11204200	Enhancers	Brain Inferior Temporal Lobe	brain
43	chr8:11204000-11204200	Bivalent/Poised TSS	Duodenum Mucosa	Duodenum
44	chr8:11204000-11204200	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
45	chr8:11204000-11204200	Bivalent/Poised TSS	GM12878-XiMat	blood
46	chr8:11204000-11204400	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
47	chr8:11204000-11204400	Flanking Active TSS	K562	blood
48	chr8:11204000-11204600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
49	chr8:11204000-11204600	Weak transcription	Gastric	stomach
50	chr8:11204000-11205000	Bivalent/Poised TSS	Pancreatic Islets	Pancreatic Islet

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links